Since when has Generex had a "standard practice" o
Post# of 36537
"MIRAMAR, FL, December 18, 2019/PRNewswire/ -- Generex Biotechnology Corporation (OTCQB: GNBT) has issued a shareholder alert regarding recent trading activity that has adversely affected the company and its shareholders. As a standard practice, Generex monitors the trading in its securities, and after due inquiry, has come to a reasonable belief that certain irregular trading activities have transpired."